Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Minerva Neurosciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −10 vs. Q1 2022
- Shares held
- 2.27M
- −191.7K (−7.8%) vs. Q1 2022Converted for a 1-for-8 split
- Total value
- $7.51M
- −$8.83M (−54.0%) vs. Q1 2022
- New holders
- 3
- 5 more added
- Sold out
- 13
- 5 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $234.8M |
| Q1 2026 | 47 | $236.1M |
| Q4 2025 | 33 | $107.7M |
| Q3 2025 | 24 | $4.21M |
| Q2 2025 | 21 | $3.34M |
| Q1 2025 | 22 | $3.31M |
| Q4 2024 | 22 | $4.63M |
| Q3 2024 | 21 | $5.65M |
| Q2 2024 | 21 | $6.65M |
| Q1 2024 | 21 | $5.42M |
| Q4 2023 | 20 | $14.9M |
| Q3 2023 | 20 | $16.6M |
| Q2 2023 | 19 | $19.0M |
| Q1 2023 | 17 | $2.69M |
| Q4 2022 | 19 | $2.75M |
| Q3 2022 | 25 | $18.7M |
| Q2 2022 | 23 | $7.51M |
| Q1 2022 | 33 | $16.3M |
| Q4 2021 | 35 | $16.6M |
| Q3 2021 | 46 | $42.9M |
| Q2 2021 | 68 | $63.2M |
| Q1 2021 | 72 | $91.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Minerva Neurosciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 3 | $0 | 0.00% | −78−96.3% | ReducedConverted for a 1-for-8 split |
| Simplex Trading, LLC | 251 | $0 | 0.00% | +245+4,362.2% | AddedConverted for a 1-for-8 split |
| Anchor Investment Management, LLC | 12 | $40 | 0.00% | −1−4.0% | ReducedConverted for a 1-for-8 split |
| TFC Financial Management | 186 | $1.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-8 split |
| UBS Group AG | 565 | $2.00K | 0.00% | +563+26,488.2% | AddedConverted for a 1-for-8 split |
| Russell Investments Group, Ltd. | 1,175 | $3.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-8 split |
| Wells Fargo & Company | 2,169 | $7.00K | 0.00% | +200+10.2% | AddedConverted for a 1-for-8 split |
| Citigroup Inc | 2,125 | $7.00K | 0.00% | +2,125 | New |
| Tower Research Capital LLC (TRC) | 3,995 | $13.0K | 0.00% | +3,449+631.0% | AddedConverted for a 1-for-8 split |
| Group One Trading, L.P. | 5,869 | $19.0K | 0.00% | +5,869 | New |
| Morgan Stanley | 6,992 | $23.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-8 split |
| Barclays PLC | 8,430 | $28.0K | 0.00% | +8,430 | New |
| State Street Corp | 13,719 | $45.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-8 split |
| Bridgeway Capital Management, LLC | 16,148 | $53.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-8 split |
| Renaissance Technologies LLC | 35,611 | $118.0K | 0.00% | −13,133−26.9% | ReducedConverted for a 1-for-8 split |
| SEI Investments Co | 37,998 | $126.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-8 split |
| Geode Capital Management, LLC | 39,837 | $131.0K | 0.00% | +1,935+5.1% | AddedConverted for a 1-for-8 split |
| BlackRock Inc. | 50,474 | $166.0K | 0.00% | −12,261−19.5% | ReducedConverted for a 1-for-8 split |
| FMR LLC | 50,127 | $166.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-8 split |
| Millennium Management LLC | 79,636 | $264.0K | 0.00% | −18,874−19.2% | ReducedConverted for a 1-for-8 split |
| Acadian Asset Management LLC | 221,084 | $732.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-8 split |
| Vanguard Group Inc | 492,077 | $1.63M | 0.00% | 00.0% | UnchangedConverted for a 1-for-8 split |
| Federated Hermes, Inc. | 1,201,275 | $3.98M | 0.01% | 00.0% | UnchangedConverted for a 1-for-8 split |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −128,000−100.0% | Sold outConverted for a 1-for-8 split |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −11,419−100.0% | Sold outConverted for a 1-for-8 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −8,194−100.0% | Sold outConverted for a 1-for-8 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −7,037−100.0% | Sold outConverted for a 1-for-8 split |
| Bailard, Inc. | 0 | $0 | 0.00% | −3,050−100.0% | Sold outConverted for a 1-for-8 split |
| Sanders Morris Harris LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold outConverted for a 1-for-8 split |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −2,463−100.0% | Sold outConverted for a 1-for-8 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −2,140−100.0% | Sold outConverted for a 1-for-8 split |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −1,738−100.0% | Sold outConverted for a 1-for-8 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,842−100.0% | Sold outConverted for a 1-for-8 split |
| Good Life Advisors, LLC | 0 | $0 | 0.00% | −1,250−100.0% | Sold outConverted for a 1-for-8 split |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −67−100.0% | Sold outConverted for a 1-for-8 split |
| Bank of America Corp | 0 | $0 | 0.00% | −18−100.0% | Sold outConverted for a 1-for-8 split |